The French drugmaker said it had entered a mandate with an “investment service provider”, with the purchase occurring between ...

According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent ...

Sanofi (NASDAQ:SNY – Free Report) by 25.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 314,180 shares of the company’s stock ...

As previously reported, L’Oréal sales in the three months ended Dec. 31 reached 11.08 billion euros, up 4.5 percent in ...

Topical steroid withdrawal syndrome may signal a reminder to clinicians to be good stewards of topical treatments, according ...

ESPN’s NFL reporter extraordinaire offers his take on this Chiefs-Eagles matchup and his life-work balance (“I sleep in ...

Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...

Although a waiver was placed on HIV/AIDS programmes in last month's U.S. foreign aid funding freeze, many concerns remained about the future of treatment programmes, the deputy executive director of ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

Civil unrest in key endemic regions, such as the Central African Republic and southwestern Cameroon, has hindered disease ...

When medical interventions fail, melanocyte keratinocyte transplantation may be the most advanced procedural option for ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for ...